• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期高迁移率族蛋白B1(HMGB1):从实验室到临床应用

High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

作者信息

Chirico Valeria, Lacquaniti Antonio, Salpietro Vincenzo, Munafò Caterina, Calabrò Maria Pia, Buemi Michele, Arrigo Teresa, Salpietro Carmelo

机构信息

Department of Pediatric Sciences, University of Messina, 98100, Messina, Italy,

出版信息

Eur J Pediatr. 2014 Sep;173(9):1123-36. doi: 10.1007/s00431-014-2327-1. Epub 2014 May 9.

DOI:10.1007/s00431-014-2327-1
PMID:24809802
Abstract

UNLABELLED

High-mobility group box protein 1 (HMGB1) is a nonhistone nuclear protein that has a dual function. Inside the cell, HMGB1 binds DNA, regulating transcription and determining chromosomal architecture. Outside the cell, HMGB1 activates the innate system and mediates a wide range of physiological and pathological responses. HMGB1 exerts these actions through differential engagement of multiple surface receptors, including Toll-like receptor (TLR)2, TLR4, and receptor for advanced glycation end products (RAGE). HMGB1 is implicated as a late mediator of sepsis and is also involved in inflammatory and autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Interestingly, HMGB1 was associated with tumor progression, becoming a potential therapeutic target, due to its involvement in the resistance to chemotherapy. Its implication on the pathogenesis of systemic vasculitis and inflammatory bowel diseases has also been evaluated. Moreover, it regulates neuroinflammation after traumatic brain injuries or cerebral infectious diseases. The aim of this review is to analyze these different roles of HMGB1, both in physiological and pathological conditions, discussing clinical and scientific implications in the field of pediatrics.

CONCLUSION

HMGB1 plays a key role in several pediatric diseases, opening new scenarios for diagnostic biomarkers and therapeutic strategies development.

摘要

未标记

高迁移率族蛋白B1(HMGB1)是一种具有双重功能的非组蛋白核蛋白。在细胞内,HMGB1与DNA结合,调节转录并决定染色体结构。在细胞外,HMGB1激活先天性免疫系统并介导多种生理和病理反应。HMGB1通过与多种表面受体(包括Toll样受体(TLR)2、TLR4和晚期糖基化终产物受体(RAGE))的不同结合来发挥这些作用。HMGB1被认为是脓毒症的晚期介质,还参与炎症和自身免疫性疾病,如类风湿性关节炎和系统性红斑狼疮。有趣的是,由于HMGB1参与化疗耐药,它与肿瘤进展相关,成为一个潜在的治疗靶点。其在系统性血管炎和炎症性肠病发病机制中的作用也已得到评估。此外,它在创伤性脑损伤或脑部感染性疾病后调节神经炎症。本综述的目的是分析HMGB1在生理和病理条件下的这些不同作用,讨论儿科学领域的临床和科学意义。

结论

HMGB1在几种儿科疾病中起关键作用,为诊断生物标志物和治疗策略的开发开辟了新的前景。

相似文献

1
High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.儿童期高迁移率族蛋白B1(HMGB1):从实验室到临床应用
Eur J Pediatr. 2014 Sep;173(9):1123-36. doi: 10.1007/s00431-014-2327-1. Epub 2014 May 9.
2
High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.高迁移率族蛋白 B1 通过 Toll 样受体 4 和晚期糖基化终产物受体抑制胃溃疡愈合。
PLoS One. 2013 Nov 11;8(11):e80130. doi: 10.1371/journal.pone.0080130. eCollection 2013.
3
High mobility group box 1 protein interacts with multiple Toll-like receptors.高迁移率族蛋白盒1与多种Toll样受体相互作用。
Am J Physiol Cell Physiol. 2006 Mar;290(3):C917-24. doi: 10.1152/ajpcell.00401.2005. Epub 2005 Nov 2.
4
High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.高迁移率族蛋白1(HMGB1):一种介导风湿性疾病发病机制的警报素
Arthritis Res Ther. 2008;10(3):209. doi: 10.1186/ar2440. Epub 2008 Jun 30.
5
Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.靶向高迁移率族蛋白 1 可改善实验性自身免疫性睾丸炎中的睾丸炎症。
Hum Reprod. 2015 Feb;30(2):417-31. doi: 10.1093/humrep/deu320. Epub 2014 Dec 1.
6
The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.高迁移率族蛋白盒1及晚期糖基化终产物可溶性受体在幼年特发性关节炎和幼年系统性红斑狼疮中的存在情况。
Pediatr Rheumatol Online J. 2014 Dec 3;12:50. doi: 10.1186/1546-0096-12-50. eCollection 2014.
7
High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.高迁移率族蛋白 B1 是全身性红斑狼疮疾病活动的潜在标志物和新的治疗靶点。
J Intern Med. 2011 Oct;270(4):309-18. doi: 10.1111/j.1365-2796.2011.02432.x.
8
HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.高迁移率族蛋白 B1-晚期糖基化终末产物受体通路驱动活性氧诱导的非酒精性脂肪性肝病相关肠病样炎症。
Redox Biol. 2017 Oct;13:8-19. doi: 10.1016/j.redox.2017.05.005. Epub 2017 May 10.
9
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.高迁移率族蛋白B1(HMGB1)通过Toll样受体(TLR)4和TLR2发出信号。
Shock. 2006 Aug;26(2):174-9. doi: 10.1097/01.shk.0000225404.51320.82.
10
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.HMGB1 抑制剂作为 HMGB1 相关疾病潜在治疗药物的概述。
Pharmacol Ther. 2014 Mar;141(3):347-57. doi: 10.1016/j.pharmthera.2013.11.001. Epub 2013 Nov 9.

引用本文的文献

1
Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances.精神医学中肝毒性的先进生物标志物:新精神活性物质的叙述性综述和建议。
Int J Mol Sci. 2023 May 28;24(11):9413. doi: 10.3390/ijms24119413.
2
Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients.游离轻链、高迁移率族蛋白B1与血液透析患者的死亡率
J Clin Med. 2022 Nov 23;11(23):6904. doi: 10.3390/jcm11236904.
3
High-mobility group box chromosomal protein-1 deletion alleviates osteoporosis in OVX rat model via suppressing the osteoclastogenesis and inflammation.

本文引用的文献

1
Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options?血清高迁移率族蛋白 B1 和干扰素-α水平及浆细胞样树突状细胞白细胞免疫球蛋白样受体-1 表达的同步变化与幼年特发性关节炎患者相关。新的治疗选择?
Lupus. 2014 Mar;23(3):305-12. doi: 10.1177/0961203313519157. Epub 2014 Jan 7.
2
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.HMGB1 抑制剂作为 HMGB1 相关疾病潜在治疗药物的概述。
Pharmacol Ther. 2014 Mar;141(3):347-57. doi: 10.1016/j.pharmthera.2013.11.001. Epub 2013 Nov 9.
3
High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children.
高迁移率族蛋白 B1 缺失通过抑制破骨细胞生成和炎症缓解去卵巢大鼠模型的骨质疏松症。
J Orthop Surg Res. 2022 Apr 12;17(1):232. doi: 10.1186/s13018-022-03110-8.
4
HMGB1: A pleiotropic activity.高迁移率族蛋白 B1:一种多效性活性。
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26(Suppl 26):63-65. doi: 10.1111/pai.13358.
5
Novel therapeutic targets for allergic airway disease in children.儿童过敏性气道疾病的新型治疗靶点
Drugs Context. 2019 Jul 9;8:212590. doi: 10.7573/dic.212590. eCollection 2019.
6
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype.NLRP3炎性小体作为骨髓增生异常综合征表型的驱动因素发挥作用。
Blood. 2016 Dec 22;128(25):2960-2975. doi: 10.1182/blood-2016-07-730556. Epub 2016 Oct 13.
7
Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression.甲氨蝶呤影响类风湿关节炎中高迁移率族蛋白B1(HMGB1)的表达,而HMGB1的下调可阻止类风湿关节炎的进展。
Mol Cell Biochem. 2016 Sep;420(1-2):161-70. doi: 10.1007/s11010-016-2783-1. Epub 2016 Aug 13.
8
Role of the diet as a link between oxidative stress and liver diseases.饮食作为氧化应激与肝脏疾病之间联系的作用。
World J Gastroenterol. 2015 Jan 14;21(2):384-95. doi: 10.3748/wjg.v21.i2.384.
9
The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.高迁移率族蛋白盒1及晚期糖基化终产物可溶性受体在幼年特发性关节炎和幼年系统性红斑狼疮中的存在情况。
Pediatr Rheumatol Online J. 2014 Dec 3;12:50. doi: 10.1186/1546-0096-12-50. eCollection 2014.
高迁移率族蛋白 B1:肥胖儿童代谢综合征的一个新生物标志物。
Eur J Endocrinol. 2013 Mar 15;168(4):631-8. doi: 10.1530/EJE-13-0037. Print 2013 Apr.
4
Neuroscience. The emerging biology of autism spectrum disorders.神经科学。自闭症谱系障碍的新兴生物学。
Science. 2012 Sep 14;337(6100):1301-3. doi: 10.1126/science.1224989.
5
Evaluation of high mobility group box 1 protein as a presurgical diagnostic marker reflecting the severity of acute appendicitis.评估高迁移率族蛋白 1 作为反映急性阑尾炎严重程度的术前诊断标志物。
Scand J Trauma Resusc Emerg Med. 2012 Sep 4;20:61. doi: 10.1186/1757-7241-20-61.
6
Genetic approach to study lupus glomerulonephritis.研究狼疮性肾炎的遗传学方法。
Methods Mol Biol. 2012;900:271-90. doi: 10.1007/978-1-60761-720-4_13.
7
Anti-high mobility group box-1 antibody therapy for traumatic brain injury.抗高迁移率族蛋白 B1 抗体治疗创伤性脑损伤。
Ann Neurol. 2012 Sep;72(3):373-84. doi: 10.1002/ana.23602. Epub 2012 Aug 22.
8
PAMPs and DAMPs: signal 0s that spur autophagy and immunity.PAMPs 和 DAMPs:刺激自噬和免疫的信号 0。
Immunol Rev. 2012 Sep;249(1):158-75. doi: 10.1111/j.1600-065X.2012.01146.x.
9
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.肿瘤浸润树突状细胞通过 TIM-3 受体与警报素 HMGB1 之间的相互作用抑制核酸介导的固有免疫反应。
Nat Immunol. 2012 Sep;13(9):832-42. doi: 10.1038/ni.2376. Epub 2012 Jul 29.
10
Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury.血浆高迁移率族蛋白 B1 水平与创伤性脑损伤患者预后的关系。
Clin Chim Acta. 2012 Nov 12;413(21-22):1737-41. doi: 10.1016/j.cca.2012.07.002. Epub 2012 Jul 10.